Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties

T. Janáky, A. Juhász, Z. Rékási, P. Serfözö, J. Pinski, L. Bokser, G. Srkalovic, S. Milovanovic, T. W. Redding, G. Halmos, A. Nagy, A. V. Schally

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Five hexapeptide and heptapeptide analogs of luteinizing hormone-releasing hormone (LH-RH) were synthesized for use as carriers for cytotoxic compounds. These short analogs were expected to enhance target selectivity of the antineoplastic agents linked to them. Native LH-RH-(3-9) and LH-RH-(4-9) containing D-lysine and D-ornithine at position 6 were amidated with ethylamine and acylated on the N terminus. The receptor-binding affinity of one hexapeptide carrier AJ-41 (Ac-Ser-Tyr-D-Lys-Leu-Arg-Pro-NH-Et) to human breast cancer cell membranes was similar to that of [D-Trp6]LH-RH. Alkylating nitrogen mustards (melphalan, Ac-melphalan), anthraquinone derivatives including anticancer antibiotic doxorubicin, antimetabolite (methotrexate), and cisplatin-like platinum complex were linked to these peptides through their ω-amino group at position 6. The hybrid molecules showed no LH-RH agonistic activity in vitro and in vivo but had nontypical antagonistic effects on pituitary cells in vitro at the doses tested. These analogs showed a wide range of receptor-binding affinities to rat pituitaries and cell membranes of human breast cancer and rat Dunning prostate cancer. Several of these conjugates exerted some cytotoxic effects on MCF-7 breast cancer cell line.

Original languageEnglish
Pages (from-to)10203-10207
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume89
Issue number21
Publication statusPublished - 1992

Fingerprint

Gonadotropin-Releasing Hormone
Melphalan
Breast Neoplasms
Cell Membrane
Antimetabolites
Mechlorethamine
Anthraquinones
Ornithine
Platinum
Methotrexate
Antineoplastic Agents
Doxorubicin
Cisplatin
Lysine
Prostatic Neoplasms
Anti-Bacterial Agents
Cell Line
Peptides
In Vitro Techniques

Keywords

  • Cancer
  • Peptides
  • Receptors on tumors
  • Targeted chemotherapeutic agents

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties. / Janáky, T.; Juhász, A.; Rékási, Z.; Serfözö, P.; Pinski, J.; Bokser, L.; Srkalovic, G.; Milovanovic, S.; Redding, T. W.; Halmos, G.; Nagy, A.; Schally, A. V.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 89, No. 21, 1992, p. 10203-10207.

Research output: Contribution to journalArticle

Janáky, T, Juhász, A, Rékási, Z, Serfözö, P, Pinski, J, Bokser, L, Srkalovic, G, Milovanovic, S, Redding, TW, Halmos, G, Nagy, A & Schally, AV 1992, 'Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties', Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 21, pp. 10203-10207.
Janáky, T. ; Juhász, A. ; Rékási, Z. ; Serfözö, P. ; Pinski, J. ; Bokser, L. ; Srkalovic, G. ; Milovanovic, S. ; Redding, T. W. ; Halmos, G. ; Nagy, A. ; Schally, A. V. / Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties. In: Proceedings of the National Academy of Sciences of the United States of America. 1992 ; Vol. 89, No. 21. pp. 10203-10207.
@article{b490b3d8e5f34066bb3c7bedae3b3bf9,
title = "Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties",
abstract = "Five hexapeptide and heptapeptide analogs of luteinizing hormone-releasing hormone (LH-RH) were synthesized for use as carriers for cytotoxic compounds. These short analogs were expected to enhance target selectivity of the antineoplastic agents linked to them. Native LH-RH-(3-9) and LH-RH-(4-9) containing D-lysine and D-ornithine at position 6 were amidated with ethylamine and acylated on the N terminus. The receptor-binding affinity of one hexapeptide carrier AJ-41 (Ac-Ser-Tyr-D-Lys-Leu-Arg-Pro-NH-Et) to human breast cancer cell membranes was similar to that of [D-Trp6]LH-RH. Alkylating nitrogen mustards (melphalan, Ac-melphalan), anthraquinone derivatives including anticancer antibiotic doxorubicin, antimetabolite (methotrexate), and cisplatin-like platinum complex were linked to these peptides through their ω-amino group at position 6. The hybrid molecules showed no LH-RH agonistic activity in vitro and in vivo but had nontypical antagonistic effects on pituitary cells in vitro at the doses tested. These analogs showed a wide range of receptor-binding affinities to rat pituitaries and cell membranes of human breast cancer and rat Dunning prostate cancer. Several of these conjugates exerted some cytotoxic effects on MCF-7 breast cancer cell line.",
keywords = "Cancer, Peptides, Receptors on tumors, Targeted chemotherapeutic agents",
author = "T. Jan{\'a}ky and A. Juh{\'a}sz and Z. R{\'e}k{\'a}si and P. Serf{\"o}z{\"o} and J. Pinski and L. Bokser and G. Srkalovic and S. Milovanovic and Redding, {T. W.} and G. Halmos and A. Nagy and Schally, {A. V.}",
year = "1992",
language = "English",
volume = "89",
pages = "10203--10207",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "21",

}

TY - JOUR

T1 - Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties

AU - Janáky, T.

AU - Juhász, A.

AU - Rékási, Z.

AU - Serfözö, P.

AU - Pinski, J.

AU - Bokser, L.

AU - Srkalovic, G.

AU - Milovanovic, S.

AU - Redding, T. W.

AU - Halmos, G.

AU - Nagy, A.

AU - Schally, A. V.

PY - 1992

Y1 - 1992

N2 - Five hexapeptide and heptapeptide analogs of luteinizing hormone-releasing hormone (LH-RH) were synthesized for use as carriers for cytotoxic compounds. These short analogs were expected to enhance target selectivity of the antineoplastic agents linked to them. Native LH-RH-(3-9) and LH-RH-(4-9) containing D-lysine and D-ornithine at position 6 were amidated with ethylamine and acylated on the N terminus. The receptor-binding affinity of one hexapeptide carrier AJ-41 (Ac-Ser-Tyr-D-Lys-Leu-Arg-Pro-NH-Et) to human breast cancer cell membranes was similar to that of [D-Trp6]LH-RH. Alkylating nitrogen mustards (melphalan, Ac-melphalan), anthraquinone derivatives including anticancer antibiotic doxorubicin, antimetabolite (methotrexate), and cisplatin-like platinum complex were linked to these peptides through their ω-amino group at position 6. The hybrid molecules showed no LH-RH agonistic activity in vitro and in vivo but had nontypical antagonistic effects on pituitary cells in vitro at the doses tested. These analogs showed a wide range of receptor-binding affinities to rat pituitaries and cell membranes of human breast cancer and rat Dunning prostate cancer. Several of these conjugates exerted some cytotoxic effects on MCF-7 breast cancer cell line.

AB - Five hexapeptide and heptapeptide analogs of luteinizing hormone-releasing hormone (LH-RH) were synthesized for use as carriers for cytotoxic compounds. These short analogs were expected to enhance target selectivity of the antineoplastic agents linked to them. Native LH-RH-(3-9) and LH-RH-(4-9) containing D-lysine and D-ornithine at position 6 were amidated with ethylamine and acylated on the N terminus. The receptor-binding affinity of one hexapeptide carrier AJ-41 (Ac-Ser-Tyr-D-Lys-Leu-Arg-Pro-NH-Et) to human breast cancer cell membranes was similar to that of [D-Trp6]LH-RH. Alkylating nitrogen mustards (melphalan, Ac-melphalan), anthraquinone derivatives including anticancer antibiotic doxorubicin, antimetabolite (methotrexate), and cisplatin-like platinum complex were linked to these peptides through their ω-amino group at position 6. The hybrid molecules showed no LH-RH agonistic activity in vitro and in vivo but had nontypical antagonistic effects on pituitary cells in vitro at the doses tested. These analogs showed a wide range of receptor-binding affinities to rat pituitaries and cell membranes of human breast cancer and rat Dunning prostate cancer. Several of these conjugates exerted some cytotoxic effects on MCF-7 breast cancer cell line.

KW - Cancer

KW - Peptides

KW - Receptors on tumors

KW - Targeted chemotherapeutic agents

UR - http://www.scopus.com/inward/record.url?scp=0026491007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026491007&partnerID=8YFLogxK

M3 - Article

C2 - 1332035

AN - SCOPUS:0026491007

VL - 89

SP - 10203

EP - 10207

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 21

ER -